Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pathology and Laboratory Medicine, |
RCV001354578 | SCV001549226 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | The CDH1 p.Gln677* variant was not identified in the literature nor was it identified in the dbSNP, ClinVar, MutDB, or Zhejiang University Database. The variant was only identified in Cosmic database (1x in urinary tract tissue). The variant was not identified in the following control databases: the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). The p.Gln677* variant leads to a premature stop codon at position 677, which is predicted to lead to a truncated or absent protein and loss of function. Loss of function variants of the CDH1 gene are an established mechanism of disease in CDH1 associated cancers and is the type of variant expected to cause the disorder. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more pathogenic role for this variant. This variant is classified as likely pathogenic. |